RAPT Therapeutics Inc (NASDAQ: RAPT) is -93.36% lower on its value in year-to-date trading and has touched a low of $0.79 and a high of $27.35 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RAPT stock was last observed hovering at around $1.74 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $1.73, the stock is 57.53% and 14.32% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.29 million and changing -0.57% at the moment leaves the stock -52.66% off its SMA200. RAPT registered -93.00% loss for a year compared to 6-month loss of -45.90%. The firm has a 50-day simple moving average (SMA 50) of $1.51886 and a 200-day simple moving average (SMA200) of $3.686415.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 52.78% gain in the last 1 month and extending the period to 3 months gives it a -6.25%, and is 96.17% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.49% over the week and 12.53% over the month.
RAPT Therapeutics Inc (RAPT) has around 131 employees, a market worth around $60.13M and $0.00M in sales. Distance from 52-week low is 119.20% and -93.67% from its 52-week high. The company has generated returns on investments over the last 12 months (-109.57%).
The EPS is expected to grow by 19.56% this year
143.0 institutions hold shares in RAPT Therapeutics Inc (RAPT), with institutional investors hold 88.24% of the company’s shares. The shares outstanding are 34.90M, and float is at 30.57M with Short Float at 5.62%. Institutions hold 86.62% of the Float.
The top institutional shareholder in the company is FMR LLC with over 5.24 million shares valued at $15.97 million. The investor’s holdings represent 13.5546 of the RAPT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 3.11 million shares valued at $9.48 million to account for 8.0472 of the shares outstanding. The other top investors are COLUMN GROUP LLC which holds 2.68 million shares representing 6.9401 and valued at over $8.18 million, while BLACKROCK INC. holds 6.3167 of the shares totaling 2.44 million with a market value of $7.44 million.
RAPT Therapeutics Inc (RAPT) Insider Activity
The most recent transaction is an insider sale by Brockstedt Dirk G., the company’s CHIEF SCIENTIFIC OFFICER. SEC filings show that Brockstedt Dirk G. sold 898 shares of the company’s common stock on Jan 05 ’24 at a price of $22.78 per share for a total of $20456.0. Following the sale, the insider now owns 27820.0 shares.
